MIRA INFORM REPORT

 

 

Report Date :

08.09.2011

 

IDENTIFICATION DETAILS

 

Name :

PRIVI ORGANICS LIMITED

 

 

Registered Office :

“Privi house”, A-71, TTC, Thane Belapur Road, Near Kopar Khairne Railway Station, Navi Mumbai – 400 709, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

05.04.1982

 

 

Com. Reg. No.:

11-026867

 

 

Capital Investment / Paid-up Capital :

Rs.357.274 millions

 

 

CIN No.:

[Company Identification No.]

U24120MH1982PLC026867

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMP17382B

 

 

PAN No.:

[Permanent Account No.]

AAACP4717A

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer, Supplier and Exporter of Aroma Chemicals

 

 

No. of Employees :

More than 400 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 3257000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealing at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INFORMATION PARTED BY

 

Name :

Mr. Shetty

Designation :

Finance Manager

Contact No.:

91-22-27783040

Date :

06.09.2011

 

 

LOCATIONS

 

Registered Office :

“Privi house”, A-71, TTC, Thane Belapur Road, Near Kopar Khairne Railway Station, Navi Mumbai – 400 709, Maharashtra, India

Tel. No.:

91-22-27783040-48

Fax No.:

91-22-27783049

E-Mail :

privi@bom3.vsnl.net.in

rameshk@privi.co.in

shetty@privi.co.in

Website :

www.privi.com

Area :

10000 sq. ft.

Location :

Owned

 

 

Corporate Office :

111-A, Karimjee Building, 2nd Floor, M.G. Road, Opposite Mumbai University,
Fort, Mumbai - 400 023, Maharashtra, India

Tel. No.:

91-22- 22662626

Fax No.:

91-22- 22623950

 

 

Factory 1 :

A7, MIDC, Mahad, Raigad – 402 309, Maharashtra, India

Tel. No.:

91-2145-232122

Fax No.:

91-2145-233494

Location :

Owned

 

 

Factory 2 :

C4 and 5, MIDC, Mahad, Raigad – 402 309, Maharashtra, India

Tel. No.:

91-2145-233245 / 232122

Fax No.:

91-2145-233754 / 233494

Location :

Owned

 

 

DIRECTORS

 

As on 15.11.2010

 

Name :

Mr. Mahesh P. Babani

Designation :

Director

Address :

Satguru House, Sherley Rajan Raod, Opposite Carter Road, Bandra, Mumbai - 400 050, Maharashtra, India

Date of Birth/Age :

01.04.1958

Qualification :

Graduate

Date of Appointment :

15.11.1989

 

 

Name :

Mr. Rahul Raisurana

Designation :

Director

 

 

Name :

Mr. Doppalapudi B. Rao

Designation :

Director

Address :

903, Daffoldils, Satguru Gardens, Thane (East) – 400 603, Maharashtra, India

Date of Birth/Age :

10.05.1946

Qualification :

Graduate

Date of Appointment :

05.04.1982

 

 

Name :

Mr. Ramchand Vatnani

Designation :

Director

Address :

New Hibndustan Co-Operative Housing Society, 113/36, 25th Road, Bandra (west), Mumbai - 400 050, Maharashtra, India

Date of Birth/Age :

06.05.1952

Qualification :

Graduate

Date of Appointment :

18.03.1999

 

 

Name :

Mr. Anoop P. Babani

Designation :

Director

Address :

Satyam House, Sherly Rajan Road, Bandra (West), Mumbai - 400 050, Maharashtra, India

Date of Birth/Age :

27.05.1954

Qualification :

Graduate

Date of Appointment :

18.03.1999

 

Directorship in other companies :

 

CIN of Company:

U29249MH1987PTC04458

Name of the company:

M J Biopharm Private Limited

Designation:

Director

 

 

CIN of Company:

U67190DL2005PTC141426

Name of the company:

Avigo Capital Partners Private Limited

Designation:

Director

 

 

CIN of Company:

U34300DL2005PTC133336

Name of the company:

Super Hoze Industries Private limited

Designation:

Director

 

 

CIN of Company:

U74899DL19990PLC041985

Name of the company:

Tecpro Systems Limited

Designation:

Director

 

 

Name :

Mr. Arjan Advani

Designation :

Director    

Address :

38, Suneeta Building, 3rd Floor, Opposite Colaba Post, Office, Colaba, Mumbai – 400 005, Maharashtra

Date of Birth/Age :

10.10.1936

Date of Appointment :

01.04.2005

 

 

Name :

Mr. Satan S. Bharwani

Designation :

Director    

Address :

Amarjeevan, St. Martin Road, Bandra, Mumbai – 400 050, Maharashtra, India

Date of Birth/Age :

01.09.1936

Date of Appointment :

01.04.2005

 

 

Name :

Mr. Rajesh H. Budhrani

Designation :

Director    

Address :

1605, Penensula Plaza, 16th Floor, 111, North bridge Road, Singapore 0617

Date of Birth/Age :

01.08.1970

Date of Appointment :

11.08.2005

 

 

Name :

Mr. Vivekanand Subramanian

Designation :

Director    

Address :

B-5/A, GF Kailash Colony, New Delhi – 110 048, India

Date of Birth/Age :

28.12.1974

Date of Appointment :

09.02.2007

 

 

Name :

Mr. Saifuddin Hakimuddin Dhorajiwala

Designation :

Alternate Director    

Address :

WI-C091, Wellington Estate, DLf City, Phase 5, Gurgaon – 122 002, Haryana, India

Date of Birth/Age :

09.08.1977

Date of Appointment :

12.02.2009

 

 

KEY EXECUTIVES

 

Name :

Mr. Shetty

Designation :

Finance Manager

 

 

Name :

Mr. Ramesh Vishanlal Kathuria

Designation :

Secretary

Address :

Shilp – II, Flat No.504, The Residency CHS, LBS Marg, Thane – 400 604, Maharashtra, India

Date of Birth/Age :

08.05.1963

Date of Appointment :

01.07.2006

 

 

Name :

Mr. Ramesh Kathuria

Designation :

Company Secretary

Address :

Shilp – II, Flat No.504, The Residency CHS, L.B.S. Marg, Thane – 400 604, Maharashtra, India

Date of Birth/Age :

08.05.1963

Date of Appointment :

01.07.2006

 

 

MAJOR SHAREHOLDERS

 

As on 15.11.2010

 

Names of Shareholders

 

 

No. of Shares

Equity Shares 

 

 

D.B. Rao

 

548450

Mahesh P. Babani

 

1813100

Ashok P. Babani

 

57250

Vivira Investment and Trading Company Private Limited, India

 

269800

Bhagwan N. Lalwani

 

50

Naveen Malkani

 

50

D. Vinay Kumar

 

365471

D. Vijay Kumar

 

133041

S R Pritmani

 

50

Mohan Malkani

 

50

V. Rajyalakshmi

 

50

 

 

 

Redeemable Cumulative Convertible Preference Shares

 

 

Avigo Trustee Company Private Limited, New Delhi, India

 

1200

Avigo Venture Investments Limited, Mauritius 

 

10799

Total

 

11999

 

 

 

Fully Compulsory Convertible Preference Shares

 

 

Avigo Trustee Company Private Limited, New Delhi, India

 

1200

Avigo Venture Investments Limited, Mauritius 

 

10800

Total

 

12000

 

As on 15.11.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign Holdings (FIIs / Fcs / FFIs / NRIs / OCBs)

 

17.58

Bodies corporate

 

14.66

Directors or relatives of directors

 

55.94

Other top fifty shareholders

 

11.82

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Supplier and Exporter of Aroma Chemicals

 

 

Products :

Item Code No. (ITC Code)

29052290

Product Description

Dihydro Myrcenol

Item Code No. (ITC Code)

29142390

Product Description

Ionones

Item Code No. (ITC Code)

29142990

Product Description

Amber Fleur

Item Code No. (ITC Code)

29121900

Product Description

Citronellol

 

 

Terms :

 

Selling :

Depend

 

 

Purchasing :

Depend 

 

 

PRODUCTION STATUS (AS ON 31.03.2010)

 

Particulars

 

Units of Measures

Installed Capacity*

Quantity

Aromatic Chemicals at A-7, MIDC, Mahad

MT

2340

Aromatic Chemicals at C-4/C5/C3/C6/C8

MT

6000

 

 

 

           

*Installed capacity is as certified by the Management and accepted by the Auditors, as it is a technical matter.

 

Note:

Under the liberalised policy of the Government vide Notification No. S-0-477 Q dated 25 July 1991 and as amended vide Press Release Note No. 4 of 1994 series dated 25 October 1994, Formulations included in above are exempted from licensing procedures under the Industries (Development and Regulation) Act, 1951.

 

Particulars

 

Production

Quantity (MT)

Aromatic Chemicals

6236.21

By Products

11025.94

 

 

 

 

GENERAL INFORMATION

 

Customers :

Industries and Manufactures

 

 

No. of Employees :

More than 400 (Approximately)

 

 

Bankers :

v      ING Vysya Bank Limited, Opera House Branch, Patel Chambers, Mumbai - 400 007, Maharashtra, India 

v      Punjab National Bank, Ilaco House, Sir P.M. Road, Fort, Mumbai – 400 001, Maharashtra, India 

v      Central Bank of India, 1st Floor, M.B. Road, Fort, Mumbai – 400 023, Maharashtra, India 

v      Corporation Bank, Veena Chambers, Dalal Street, Fort, Mumbai – 400 023, Maharashtra, India 

v      Bank of Baroda, Mulji Jetha Building, 185/187, Princess Street, Mumbai – 400 002 (Joined the consortium w.e.f 31.01.2005)

v      Export Import Bank of India, Cuffe Parade, Mumbai, Maharashtra, India 

v      HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400 013, Maharashtra, India

 

 

Facilities :

 

Secured Loans

31.03.2010

(Rs. In Millions)

31.03.2009

(Rs. In Millions)

Loans from financial institutions

 

 

Term loans in Indian Rupees

152.381

152.381

Term loans in Foreign Currency (USD)

45.435

68.378

Vehicle Loans (Secured by hypothecation of the respective vehicles)

1.430

2.956

Loan from banks

 

 

Term loans in Foreign Currency (USD)

354.060

329.273

Vehicle Loans (Secured by hypothecation of the respective vehicles)

0.099

0.603

Working Capital Loans

231.489

420.101

Total

784.894

973.692

 

Notes:

 

a) Term loans and vehicle loans from banks and financial institutions include amounts repayable within one year aggregating to Rs.124.324 millions (2009: Rs.159.876 millions). During the current year the Company has restructured the term loans by which the term of the loans have been extended by additional year.

 

b) Loan from financial institutions include Rupee Term Loan From Exim Bank Rs.152.381 millions (2009: Rs.152.381 millions) and Term loan from Exim Bank in foreign currency USD 1006542.96 equivalent to Rs.45.435 millions (2009: USD 1342057.12 equivalent to Rs.68.378 millions)   are secured by a first mortgage on the Company's immovable properties both present and future ranking pari passu interest and a first charge by way of hypothecation of all the Company's assets (save and except book debts and inventories) including movable machinery (save and except spares tools and accessories) both present and future subject to charges created in favour of the Company's bankers for inventories, book debts and other specified movable for securing the borrowings of Working Capital and by way of personal guarantees of Directors and their relatives.

 

c) Loan from banks include Term loan from Bank of Baroda in foreign currency USD 1329699.20 equivalent to Rs.60.023 millions (2009: USD 1462660.05 equivalent to Rs.74.523 millions) and Term loan from ABN Amro Bank in foreign currency USD 6513888 equivalent to Rs.294.037 millions (2009: USD 5000000 equivalent to Rs.254.750 millions) are secured by a first mortgage on the Company's immovable properties both present and future ranking pari passu interest and a film charge by way of hypothecation of all the Company's assets (save and except book debts and inventories) including movable machinery (save and except spares tools and accessories) both present and future subject to charges created in favour of the Company's bankers for inventories, book debts and other specified movable for securing the borrowings of Working Capital and by way of personal guarantees of Directors and their relatives.

 

d) Working Capital Loan from banks are secured by way of hypothecation of inventories both on hand and in transit and book debts and other receivables both present and future and also secured by way of second charge on fixed assets, Collateral Security of Land by way of Equitable Mortgage of Immovable property belonging to a Director and his family members and by way of personal guarantees of Directors and their relatives.

 

Unsecured Loans

31.03.2010

(Rs. In Millions)

31.03.2009

(Rs. In Millions)

Loans from Shareholders

0.470

0.570

Sales Tax Deferred

62.726

65.922

Loans from Department of Bio-technology (Note 2)

3.120

1.560

Total

66.316

68.052

 

1. Amount repayable within one year is and Nil (2009 and Nil)

 

2. The Company has received two installments of Grant-in-aid and loan from the Department of Biotechnology, Ministry of Science and Technology under Small Business Innovation Research Initiative (SBIRI) scheme for "Enzyme Catalyzed Manufacture of esters" out of the sanctioned Grant-in-aid of Rs.3.000 millions and loan of Rs.6.240 millions. The aid is received in the form of Grant for the revenue expenditure Rs.0.750 million (2009: Rs 0.750 million) on research and development and has been credited as income and loan Rs.1.560 millions (2009: Rs.1.560 millions) for funding the man-power costs in relation to the Project. The loan is repayable to the Government in ten equal yearly installments with effect from March, 2011.

 

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

 

 

Name 1 :

BSR Associates

Chartered Accountants 

Address :

Lodha Excelus, 1st Floor, Apollo Mills Compound, N.M. Joshi Marg, Mahalakshmi, Mumbai – 400 011, Maharashtra, India

Tel. No.:

91-22-39896000

Fax No.:

91-22-39836000

 

 

Name 2 :

BRV And Associates

Chartered Accountants

Address :

301, Crystal Tower, 46/48, Maruti Lane Near Handloom House, Fort, Mumbai, Maharashtra, India

 

 

Memberships :

Basic Chemicals, Pharmaceuticals and Cosmetics Export Promotion   Council

Fragrances and Flavours Association of India

 

 

Related Parties (Enterprises owned or significantly influenced by key management personnel or their relatives) :

v      Satguru Construction (Andheri)

v      Vivira Chemical Industries

v      Vivira Chemicals Private Limited

v      Privi Pharma Private Limited

v      Minar Organics Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

16000000

Equity Shares 

Rs.10/- each

Rs.160.000 millions

12000

0.1% Redeemable Cumulative Convertible Preferences Shares

Rs.10000/- each

Rs.120.000 millions

12000

0.1% Fully Compulsorily Convertible Preferences Shares

Rs.10000/- each

Rs.120.000 millions

 

Total

 

Rs.400.000 millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

11728431

Equity Shares 

Rs.10/- each

Rs.117.284 millions

11999

0.1% Redeemable Cumulative Convertible Preferences Shares

Rs.10000/- each

Rs.119.990 millions

12000

0.1% Fully Compulsorily Convertible Preferences Shares

Rs.10000/- each

Rs.120.000 millions

 

Total

 

Rs.357.274 millions

 

NoteS:

 

a) Out of the above 8065360 Equity Shares of Rs.10/- each issued as fully paid bonus by utilizing balance in securities premium account and profit and loss account.

 

b) As the shareholders agreement the redeemable cumulative convertible preferences shareholders have a right to exercise an option based on the audited financials as at 31.03.2009. Notwithstanding the foregoing, the same shall get automatically converted as on 31.12.2010.

 

c) As per the shareholder’s agreement the compulsorily convertible preference shares shall be converted on 31.12.2010 based on the profit after tax as required in the audited financials as at 31.03.2009. The shareholders have not exercised the right of conversion.

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

357.274

357.274

357.274

2] Share Application Money Pending Allotment

0.000

0.000

0.100

3] Reserves & Surplus

457.068

287.922

354.086

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

814.342

645.196

711.460

LOAN FUNDS

 

 

 

1] Secured Loans

784.894

973.692

687.759

2] Unsecured Loans

66.316

68.052

66.892

TOTAL BORROWING

851.210

1041.744

754.651

DEFERRED TAX LIABILITIES

49.169

9.550

44.358

 

 

 

 

TOTAL

1714.721

1696.490

1510.469

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

882.679

741.982

502.543

Capital work-in-progress (including capital advances)

133.942

222.004

315.233

 

 

 

 

INVESTMENT

3.336

2.662

3.287

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

619.749
610.855

600.777

 

Sundry Debtors

675.090
604.869

543.354

 

Cash & Bank Balances

109.467
106.949

63.766

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

206.242
142.602

133.657

Total Current Assets

1610.548
1465.275

1341.554

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

817.035

683.027

613.796

 

Other Current Liabilities

41.207
43.223

34.023

 

Provisions

59.375
12.547

10.117

Total Current Liabilities

917.617
738.797

657.936

Net Current Assets

692.931
726.478

683.618

 

 

 

 

MISCELLANEOUS EXPENSES

1.833

3.364

5.788

 

 

 

 

TOTAL

1714.721

1696.490

1510.469

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Sales (Net)

2627.697

2294.180

1929.914

 

 

Other Income

9.625

10.203

6.523

 

 

Foreign Currency Fluctuations Gain (Net)

115.683

0.000

34.829

 

 

TOTAL                                     (A)

2753.005

2304.383

1971.266

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Materials Cost

1865.182

1570.789

1442.286

 

 

Increase/ Decrease in Inventory

12.151

1.270

(117.410)

 

 

Personal Cost

99.017

89.083

69.843

 

 

Manufacturing and Other Expenses

274.154

260.283

246.760

 

 

Administrative and Selling Expenses

90.698

121.403

104.840

 

 

Foreign Currency Fluctuations Loss (Net)

0.000

171.003

0.000

 

 

Prior Period Items (Net)

0.234

12.729

0.142

 

 

TOTAL                                     (B)

2341.436

2226.560

1746.461

 

 

 

 

 

Less

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

411.569

77.823

224.805

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

81.857

106.416

77.272

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

329.712

(28.593)

147.533

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

94.363

67.780

52.835

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

235.349

(96.373)

94.698

 

 

 

 

 

Less

TAX                                                                  (H)

65.922

(30.490)

23.559

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX (G-H)                  (I)

169.427

(65.883)

71.139

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

134.845

201.009

130.027

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend on Preference Shares

0.240

0.240

0.134

 

 

Provision for Dividend Distribution Tax

0.041

0.041

0.023

 

BALANCE CARRIED TO THE B/S

303.991

134.845

201.009

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of goods on FOB basis

1683.452

1335.148

1182.644

 

TOTAL EARNINGS

1683.452

1335.148

1182.644

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

1334.391

991.678

882.053

 

 

Capital Goods

0.000

5.946

29.443

 

TOTAL IMPORTS

1334.391

997.624

911.496

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

14.43

(5.62)

6.39

 

 

Particulars

 

 

 

31.03.2011

Sales Turnover (Approximately)

 

 

3750.000

 

 

 

 

 

The above information has been parted by Mr. Shetty (Finance Manager).

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

6.15

(2.86)

3.60

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

8.95

(4.20)

4.91

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets)

(%)

9.43

(3.96)

4.38

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.28

(0.15)

0.13

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

2.17

2.76

1.99

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

9.50

1.98

2.04

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors:

 

Particulars

 

31.03.2010

(Rs. in millions)

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

Sundry Creditors

 

 

 

- Dues to Micro and Small Enterprise (Note)

--

--

--

- Others

817.035

683.027

613.796

 

817.035

683.027

613.796

 

Note:

On the basis of information and records available with the Company, there are no outstanding dues as at 31 March 2010 and 31 March 2009 to the Micro and small enterprises as defined in the Micro, Small and Medium Enterprises Development Act, 2006.

 

change of address:

 

The Registered office of the company was 205, Princess Street, Mumbai - 400 002, Maharashtra change to present registered address w.e.f. 28.09.2007.

 

BACKGROUND

 

Subject is manufacturer, supplier and exporter of aroma chemicals.

 

Privi started manufacturing aroma chemicals in the year 1992 with only two products, which it gradually expanded to a range of over 50 products. Privi also develops and produces custom-made aroma chemicals as per specific requirement of the customer. The Company's manufacturing units are located at Mahad. Privi's in-house Research and Development centre at Mahad has been accorded recognition by the Department of Scientific and Industrial Research.

 

FINANCIAL AND OPERATIONAL REVIEW:

 

The year marked stabilization of their growth plans embarked upon in the last three years. After experiencing one of the biggest global economic and financial meltdown witnessed in 2008-09 - since the 1931 recession – the Company has been able to smartly turn around its performance and has achieved a Profit before Tax of Rs.235.349 millions.

 

The Company achieved a net sales turnover of Rs.2627.697 millions (Previous year Rs.2294.180 millions) registering a growth of 15%. While the export sales turnover grew by 25%, the local sales turnover grew by a modest 13%.

 

The Company's net worth as on March 31, 2010 was Rs.812.509 millions, with paid-up capital of Rs.357.274 millions, accumulated reserves and surplus of Rs.457.068 millions as reduced by Rs.1.833 millions miscellaneous expenditure not written off.

 

MANAGEMENT DISCUSSION AND ANALYSIS

 

India's economy grew at 8.6%, its fastest pace in six months in the quarter through March 2010, fuelled primarily by government and consumer spending. India's GDP growth for the whole fiscal 2009-10 was estimated to be 7.4 %, compared with 6.8% attained in 2008-09, ending with better-than-expected growth rate. The Index of Industrial Production numbers has also shown an improvement. The industrial production grew at 10% for the 1 I-month period, i.e. from April 2009 to February 2010, which is much higher than the growth achieved in the previous year; the industrial growth rate has further accelerated in 2011. However, inflation and fiscal deficit continue to be major concerns for the government.

 

India's chemical industry is expected to grow into a 150 billion dollar (about Rs.7040000.000 millions) market by 2013, riding on fast economic growth and strong domestic demand. India's chemical industry has a promising future and is expected to see around 9-10 per cent growth annually. The main drivers propelling the growth include the lower cost advantage, substantial domestic demand and government focus on providing incentives, along with improving infrastructure capabilities. Moreover, India also possesses a rich source of talent and skilled people, which also makes it attractive for global firms.

 

GLOBAL FRAGRANCE MARKET OVERVIEW:

 

The economic environment continued to be difficult during the year 2009-10 and hence was a testing year for the global fragrance market. The adverse economic conditions caused drop in consumer spending in mature markets, particularly in discretionary segment such as fine fragrance. Segments such as Consumer products proved their natural resilience across global markets. Consumer products business across globe fared well in the developing countries and demand was strong in Brazil, India and China.

 

The first quarter of financial year was challenging, but in the subsequent quarters demand improved providing business momentum throughout the year.

 

Keeping abreast of customer requests and constantly striving to demand-supply changes, the Company has been creating a diversified product portfolio. This has resulted in growth of sales and an improved bottom line.

 

KEY MILESTONES:

 

Some of the Key Milestones for the year were:

 

1) The Company was able to get back its share of global markets, post last year's economic recession, and export sales grew by 25%.

2) Capacity expansion of key products: Privi was able to successfully commission increased capacity of two major products thereby leading to increased output for these products.

3) Two of the top five global fragrance houses have selected the Company as a lead supplier for DHMOL and Amber Fleur (fastest growing products).

4) Set up a new specialty aroma chemical plant which would contribute Rs.250.000 millions in revenue from the next fiscal year.

 

CHALLENGES:

 

The Company has continuously innovated and expanded capacities ahead of competition to gain market share for its key products. This will continue to be the key challenge the Company needs to address while going forward. Although global economy has shown signs of recovery, there is considerable uncertainty particularly in the USA, Europe and Japan. The Company is not completely insulated from the effects of economic slowdown.

 

'REACH': The Company is participating in SIEF meetings to understand the cost impact of registration on the Company. A dedicated team is working on ways to minimize the cost impact through strategic meetings with the lead registrant. The Company has taken initiatives to be compliant with CLP and MSDS requirements as per REACH guidelines, from the current year onwards.

 

Competition: The Company faces competition in two flagship products namely DHMOL and Amber Fleur. Amber Fleur competition is stiffer, due to capacities set up by new entrants into the market. The Company has been able to grow its market share on account of better product quality and better service levels in the face of increased competition.

 

OUTLOOK

 

The Company has seen revival in demand for its products early this year. Large buyers like Firmenich and Givaudan have seen positive signs in terms of business momentum from Q2 of calendar year 2009. The demand for consumer products has been strong in Brazil, India and China, from where the top five fragrance houses see their growth. Demand for consumer products in developed nations such as the USA, Europe and Japan has been resilient. The Company sees its growth coming from key accounts in emerging and developing countries and its product mix will enable the Company to increase its share of revenue coming from specialty aroma chemicals.

 

FUTURE PROJECTS AND EXPANSION

 

The Company is further consolidating its strength in its flagship products namely DHMOL and Amber Fleur through backward integration process. Processing of Crude Sulphate Turpentine (CST) to obtain both Alpha Pinene and Beta Pinene is underway, along with augmenting of the production capacities

 

CST processing would lower the cost of manufacturing DHMOL and Amber Fleur and also provide raw material security which has been a cause of concern in the past few years.

 

The Company is also in the process of setting up a multi-product specialty chemical plant for production of new products. These strategically selected products have been successfully manufactured at the pilot plant and samples of the same have been approved by their major customers. These products and the use of petrochemical-based raw materials, rather than citral and pinenes, whose availability in sufficient quantities has become difficult should give them good margins.

 

The Directors are confident that based on the strategies outlined above, the Company's performance should improve in the financial year 2010-1 1 onwards. However, external factors such as changes in general economic and business conditions due to global economic outlook, currency exchange rates and interest rates, introduction of competing products, levy of higher duties by importing countries could materially affect the demand for the products of the Company and thereby affect the performance projections.

 

CONTINGENT LIABILITIES (AS ON 31.03.2010)

 

a) Not provided for

 

Particulars

 

31.03.2010

(Rs. in millions)

Demand of Rs.1.552 millions (net of Rs.0.600 million paid) raised by Customs, Excise and Service Tax Appellate Tribunal West Zonal Bench Mumbai for clearance of imported goods under DEPB scheme. (Contravention of the provisions of Section 111 (o) of the Customs Act 1962)

1.552

Demand raised by Income Tax Authorities

7.803

 

b) Derivatives.

 

As at 31 March 2009, the Company had contracted with the banks for certain foreign currency derivatives transactions to hedge its foreign currency exposures which have maturity upto October 2011.

 

The mark to market (MTM) valuation of open derivatives outstanding as at 31 March 2009, in accordance with the announcement dated 29 March 2008 by the Institute of Chartered Accountants of India, indicated basic net loss of Rs.50.599 millions (loss after tax Rs.38.719 millions and deferred tax liability Rs.11.880 millions). Since these contracts had long dated tenor with multiple contingent/ uncertain events and the contracted foreign currency is intended to be delivered on and around stipulated dates, the management was of the opinion that the said loss is notional loss and not crystallized as on the balance sheet date. Accordingly the same was not provided for in the financial statements as at 31 March 2009. During the current year there is a mark to market gain on foreign currency derivates outstanding as at 31 March 2010. Since the Company has not recorded the mark to market loss as at 31 March 2009, the Company has not recorded the recoupment of that mark to market loss during the year ended 31 March 2010. Consequently the profit after tax (net) for the year ended 31 March 2010 would have been higher by Rs.38.719 millions, however this does not have an impact on the reserves and surplus as at that date.

 

form 8:

 

Corporate identity number of the company

U24120MH1982PLC026867

Name of the company

PRIVI ORGANICS LIMITED

Address of the registered office or of the principal place of  business in India of the company

“Privi house”, A-71, TTC, Thane Belapur Road, Near Kopar Khairne Railway Station, Navi Mumbai – 400 709, Maharashtra, India

E-Mail: rameshk@privi.co.in

This form is for

Creation of charge

Type of charge

Movable Property

Particular of charge holder

CIN No.: L65920MH1994PLC080618

HDFC Bank Limited, HDFC Bank House, Senapati Bapat Marg, Lower Parel (West), Mumbai – 400 013, Maharashtra, India

E-Mail: vivek.vazirani@hdfcbank.com

Nature of description of the instrument creating or modifying the charge

Memorandum relating to Hypothecation of Machinery

Date of instrument Creating the charge

02.05.2011

Amount secured by the charge

Rs.167.660 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

The Loan will carry interest at LIBOR  + 500 % (LIBOR plus Five Hundred Percent)

 

Terms of Repayment:

Quarterly Installment of USD 490000 already been paid.

12 Quarterly installments of USD 213247.65 starting from 05.06.2011 to 05.03.2014.

8 Quarterly installments of   USD   83878.62 starting from 05.06.2011 to 05.03.2013.

 

Margin:

N.A.

 

Extent and Operation of the charge:

First pari passu charge on movable Plant Machinery (except spare tools and accessories) both present and future

 

Others:

None

Short particulars of the property charged

All the movable Plant and Machinery both present and future consisting of all Company assets (except book debt and Inventories) including movable machinery (except spares tools and accessories) stored at MIDC Mahad A-3,A-7, C-3,4,5,6,6/1,8/,33,/1X-9,10,11 and at A-71, TTC Thane Belapur Road, Navi Mumbai.

 

 

Name of the company

PRIVI ORGANICS LIMITED

Presented By

ING Vysya Bank Limited

1) Date and description of instrument creating the change

  • Working Capital Construction Agreement
  • Joint Deed of Hypothecation both dated 4th March 2004 and create single charge

2) Amount secured by the charge/amount owing on the securities of charge

Rs.285.000 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Hypothecation by way of first pari passu charge on whole of the current assets viz. stock of raw material, stock in process, Semi finished and finished goods, stores and spares not relating to plant and machinery, equipments, vehicle, computers, furniture, fixture, wherever or wherever  in transit both present and future

4) Gist of the terms and conditions and extent and operation of the charge.

Interest and margin as per sanction letter of respective banks.

Security to secure funded and non-funded facilities granted by INB Vysya Rs.91.500 Millions (F-Rs.31.500 Millions, NF- Rs.60.000 Millions) PNB Rs.40.000 Millions Rs.20.000 Millions, NF-Rs.20.000 Millions)CBI Rs.70.000 Millions (F-Rs.30.000 Millions, NF-Rs.40.000 Millions)and CB Rs.83.500 Millions (f-Rs.33.500 Millions, NF- Rs.50.000 Millions) together with interest, cost, expenses, charges, commission etc.

5) Name and Address and description of the person entitled to the charge.

  • ING Vysya Bank Limited. (IVB) Opera House Branch, Patel Chambers, Mumbai - 400 007.
  • Punjab National Bank, (PNB) Ilaco House, Sir P.M. Road, Fort, Mumbai - 400001
  • Central Bank of India, (CBI) 1st Floor, M.B. Road, Fort, Mumbai;400023
  • Corporation Bank, (CB) Veena Chambers, Dalal Street, fort, Mumbai-400023
  • Bank of Baroda, (BOB) Mulji Jetha Building, 185/187, Princess Street, Mumbia;400002

(Joined the consortium w.e.f 31.01.2005)

6) Date  and brief description of instrument modifying the charge

Second Supplemental Joint Deed of Hypothecation dated 20.12.2005

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

The original Charge dated 04.03.2004 for Rs.285.000 Millions was modified on 31.01.2005 enhancing the total charge from Rs.285.000 Millions to Rs.475.000 Millions consisting of funded and non-funded facilities granted by INB Vysya Rs.131.500 Millions (F-rs.61.500 Millions, NF-Rs.70.000 Millions) PNB Rs.130.000 Millions (F-Rs.56.000 Millions, NF- Rs.74.000 Millions) CBI Rs.70.000 Millions )F-Rs.30.000 Millions NF-Rs.40.000 Millions), CB Rs.83.500 Millions (F-Rs.333.500 Millions, NF Rs. 50.000 Millions ) and BOB Rs.60.000 Millions (F-Rs.24.000 Millions, NF- Rs.36.000 Millions)

 

Bank of Boroda, Mulji Jetha Bluiding, 185/187, Princess Street, Mumbai - 400002, was joined the consortium.

 

Now further modified on 20.12.2005 enchancing the total charge from Rs.475.000 Millions to Rs. 600.000 Millions Consisting of funded and non-funded facilities granted by IVB Rs.186.000 Millions (F-Rs.75.000 Millions, NF-Rs.111.000 Millions) PNB Rs.184.000 Millions (F-Rs.80.000 Millions, NF-Rs.104.000 Millions), CB Rs.90.000 Millions (F-Rs.35.000 Millions NF-55.000 Millions) and BOB Rs.140.000 Millions (F-Rs.60.00 Millions, NF-Rs.80.000 Millions)

 

Central Bank of India ceased to be a member of consortium

 

Fixed Assets:-

 

·         Lease hold Land

·         Buildings

·         Staff quarters

·         Plant and Machinery

·         Electrical Installations

·         Furniture

·         Office Equipments

·         Computers

·         Computers software

·         Lab Equipments

·         Vehicles

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.46.02

UK Pound

1

Rs.73.61

Euro

1

Rs.64.78

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.